Compare AIZ & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AIZ | KRYS |
|---|---|---|
| Founded | 1892 | 2015 |
| Country | United States | United States |
| Employees | 14800 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2B | 9.6B |
| IPO Year | N/A | 2017 |
| Metric | AIZ | KRYS |
|---|---|---|
| Price | $264.00 | $355.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 11 |
| Target Price | $256.83 | ★ $297.60 |
| AVG Volume (30 Days) | ★ 398.4K | 288.6K |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | N/A | ★ 128.00 |
| EPS | N/A | ★ 1.83 |
| Revenue | N/A | ★ $389,130,000.00 |
| Revenue This Year | $7.39 | $38.74 |
| Revenue Next Year | $5.52 | $32.53 |
| P/E Ratio | ★ $12.98 | $190.20 |
| Revenue Growth | N/A | ★ 33.94 |
| 52 Week Low | $183.39 | $130.50 |
| 52 Week High | $265.66 | $356.50 |
| Indicator | AIZ | KRYS |
|---|---|---|
| Relative Strength Index (RSI) | 66.31 | 75.17 |
| Support Level | $230.25 | $253.89 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 4.99 | 12.26 |
| MACD | 0.20 | 3.90 |
| Stochastic Oscillator | 91.11 | 96.33 |
Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions, consumer electronics and appliances services, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. In addition, the Company reports the Corporate and Other segment, which includes corporate employee-related expenses, activities of the holding company and investments in the home warranty business.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.